EW:NYSE
Edwards Lifesciences Corp
$105.80
arrow_downward
-0.01%(-0.0100) 1D
$105.80
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 12, 4:00:03 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EW...
Open
$106.07
High
$106.80
Low
$104.93
Mkt. cap
60.84B
Avg. vol.
4.48M
Volume
4.16M
P/E ratio
59.98
52-wk high
$106.80
52-wk low
$74.66
EPS
$1.76
Beta
0.85
Shares outstanding
575.00M
No. of employees
16K
Open
$106.07
High
$106.80
Low
$104.93
Mkt. cap
60.84B
Avg. vol.
4.48M
Volume
4.16M
P/E ratio
59.98
52-wk high
$106.80
52-wk low
$74.66
EPS
$1.76
Beta
0.85
Shares outstanding
575.00M
No. of employees
16K
News stories
From web sources and news partners
Zacks
·
5 hours ago
Boston Scientific Bets on WATCHMAN Growth Despite Market Slowdown
Investing.com
·
1 day ago
Edwards Lifesciences stock hits 52-week high at 105.39 USD
Investing.com
·
3 days ago
Edwards Lifesciences stock rating maintained at Buy by TD Cowen
Profile
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
About Edwards Lifesciences Corp
CEO-
Employees16K
Founded1958
HeadquartersIrvine, California, United States
SectorHealth Care
IndustryMedical device
Websiteedwards.com